Vitenskapelige publikasjoner og rapporter utgått fra Senter for aldersforskning i Tromsø

(Oversikten er basert på tilbakemelding fra forskerne og årsmeldingene fra 1997- 2006)

MEDISINSK FORSKNING:

Luai Awad Ahmed:
Ahmed LA, Schirmer H, Fønnebø V, Joakimsen RM, Berntsen G. 2006. Validation of the Cummings risk score; how well does it identify women with high risk of hip fracture: The Tromsø Study. Eur J Epidemiol 21: 815-822.

Jørgensen L, Joakimsen O, Mathiesen, E, Ahmed LA, Berntsen G, Fønnebø V, Joakimsen R, Njølstad I, Schirmer H, Jacobsen BK. 2006. Carotid plaque echogenicity and risk of non-vertebral fractures in women. A longitudinal population-based study. Calcif Tissue Int. 79: 207-13

Torgeir Engstad:
Engstad T, Bønaa K, Viitanen M. 2000. The validity of self-reported stroke. The Tromsø Study. Stroke 31:1602-1607.

Engstad T, Viitanen M, Arnesen E. 2003. Impaired Motor Speed, Visuospatial Episodic Memory and Verbal Fluency Characterize Cognition in Long-Term Stroke Survivors: The Tromsø Study. Neuroepidemiology 22: 326-331.

Engstad T, Almkvist O, Viitanen M, Arnesen E. 2003. Predictors of Death Among Long-Term Stroke Survivors. Stroke 34: 2876-2880.

Knut Holtedahl:
Holtedahl K, Norum J, Anvik T, Richardsen E. 2005. Do cancer patients benefit from short-term contact with a general practitioner following cancer treatment? Randomised, controlled study. Supportive care in cancer 13: 949-956.

Anvik T, Holtedahl KA, Mikalsen H. 2006. When patients have cancer, they stop seeing me” – the role of the general practitioner in early follow-up of patients with cancer – a qualitative study. BMC Family Practice 7:19 doi:10.1186/1471-2296-7-19

Elena Kamycheva:
Kamycheva E, Joakimsen R, Jorde R. 2003. Intakes of calcium and vitamin D predict body mass index in the population of Northern Norway. Journal of Nutrition 133:102-106.

Kamycheva E, Sundsfjord J, Jorde R. 2004. Serum parathyroid hormone levels predict coronary heart disease: the 5th Tromsø Study. European Journal of cardiovascular Prevention and Rehabilitation 11:69-74.

Kamycheva E, Sundsfjord J, Jorde R. 2004. Serum parathyroid hormone is a predictor of increased body mass index. The 5th Tromsø Study. European Journal of Endocrinology 151:167-172.

Kamycheva E, Jorde R, Haug E, Sager G, Sundsfjord J. 2005. Effects of acute hypercalcaemia on blood pressure in subjects with and without parathyroid hormone secretion. Acta Physiologica Scandinavica 184:113-119.

Kamycheva E, Jorde R, Haug E. Insulin sensitivity in relation to serum parathyroid hormone and 25-hydroxyvitamin D. J Endocrinol Invest, in press 2006.

Einar Laukli:
Laukli E, Molde B, Solem BS, Stenklev NC. 2001. Hearing in the elderly: a test protocol and preliminary results. Scandinavian Audiology 30 (suppl 52): 167-70.

Stenklev NC, Laukli E. 2003. Transient otoacousticemissions in the elderly. International Journal of Audidology 42: 132-139.

Stenklev NC, Laukli E. 2004. Presbyacusis - hearing thresholds and the ISO 7029. International Journal of Audidology 43: 295-306.

Ellisiv B. Mathiesen:
Mathiesen EB. 2002. The role of plaque echogenicity in carotid stenosis: Increased risk of ischemic stroke in persons with echolucent plaques. Cardiovascular Reviews & Reports 23: 561-564.

Mathiesen EB, Bønaa KH, Joakimsen O. 2001. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis. The Tromsø Study. Circulation 103: 2171-2175.

Mathiesen EB, Bønaa KH, Joakimsen O. 2001. Low high-density lipoprotein is associated with echolucent, soft carotid artery plaques. The Tromsø Study. Stroke 32: 1960-1965.

Mathiesen EB, Joakimsen O, Bønaa KH. 2001. Prevalence of and risk factors associated with carotid artery stenosis. The Tromsø Study. Cerebrovascular Diseases 12: 44-50.

Mathiesen EB, Joakimsen O, Bønaa KH. 2000. Intersonographer reproducibility and intermethod variability of ultrasound measurements of carotid artery stenosis. The Tromsø Study. Cerebrovascular Diseases 10: 207-213.

James J. Mercer:
Mercer JB, Østerud B, Tveita T. 1999. The effect of short term cold exposure on risk factors for cardiovascular disease. Thrombosis Research 95: 93-104.

Bård Smedsrød:
Arbeider som er publisert fra min gruppe, innen rammen av det prosjekt som støttes av SAT:

Elvevold K, Nedredal GI, Revhaug A, Bertheussen K, Smedsrød, B. 2205. Long term preservation of high endocytic activity in primary cultures of pig liver sinusoidal endothelial cells. Eur. J.Cell Biol 84: 749-764.

Falkowski M, Skogstad S, Shahzidi S, Smedsrød B, Sveinbjørnsson B. 2003. The effect of cyclooxogenase inhibitor diclofenac on experimental murine colon carcinoma. Anticancer Research 23: 3-8.

Hansen B, Svistounov D, Horiuchi S, Smedsrød B. 2001. The effect of advanced glycation end products on endocytic scavenger function in hepatic scavenger endothelial cells. In: Cells of the hepatic sinusoid (eds.: E Wisse, D Knook, De Zanger, M Arthur). Vol. 8, Kupffer Cell Foundation, Leiden, The Netherlands, pp 132–135.

Hansen B, Artea B, Smedsrød B. 2002. The physiological scavenger receptor function of hepatic sinusoidal endothelial and Kupffer cells is independent of scavenger receptor class A type I and II. Molecular & Cellular Biochemistry 240: 1-8.

Hansen B, Svistounov D, Olsen R, Nagai R, Horiuchi S, Smedsrød B. 2002. Advanced glycation end products lower the clearance function of rat hepatic scavenger endothelial cells. Diabetologia 45: 1379–1388.

Hansen B, Longati p, Elvevold K, Nedredal GI, Schledzewski K, Olsen R, Falkowski M, Kzhyshkowska J, Carlsson F, Johansson S, Smedsrød B, Goerdt S, Johansson S, McCourt P. 2005. Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding. Exp Cell Res. 303: 160-173.

Holmström P, Dzikaite V, Hultcrantz R, Melefors Ö, Eckes K, Kinnmann N, Smedsrød B, Stål P, Gåfvels M, Eggertsen G. Structure and liver cell expression pattern of the HFE gene in the rat. Journal of Hepatology 39: 308-314.

Martin-Armas M, Simon-Santamaria J, Pettersen I, Smedsrød, B, Sveinbjørnsson B. 2005.Toll Like Receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. J. Hepatol. Nov 7 (Epub ahead of print).

Matsumoto K, Sano H, Nagai R, Suzuki H, Kodama T, Yoshida M, Ueda S, Smedsrød B, Horiuchi S. 2000. Endocytic uptake of advanced glycation end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor class A. Biochemical Journal 352: 233–240.

McCourt, PAG, Smedsrod, B, Melkko, J, Johansson, S. 1999. Characterization of a hyaluronan receptor on rat sinusoidal liver endothelial cells and its functional relationship to scavenger receptors. Hepatology 30: 1276–1286.

McCourt PAG, Hansen B, Svistounov D, Johansson S, Longati P, Schledzewski K, Kzhyshkowska J, Goerdt S., Smedsrød B. 2003. The liver sinusoidal endothelial cell hyaluronan scavenger receptor and its homologue,Stabilin-1 – their roles (known and unknown) in endocytosis. Hyaluronan 2003, Cleveland, Ohio, USA.

Mousavi SA, Sato M, Sporstol M, Smedsrød B, Berg T, Kojima N, Senoo H. 2005. Utake of denatured collagen into hepatic stellate cells: Evidence for the involvement of urokinase plasminogen activator associated protein/Endo 180. Biochem J. 387: 39-46.

Nedredal GI, Elvevold KH, Ytrebø LM, Olsen R, Revhaug A, Smedsrød B. 2003. Liver sinusoidal endothelial cells represent an important blood clearance system in pig. Comparative Hepatology 2: 1-14.

Overland G, Morath S, Yndestad A, Hartung GT, Thiemermann C, Foster SJ, Smedsrød B, Mathiesen Ø, Aukrust P, Aasen AO, Wang JE. 2003. Lipoteichoic acid as a potent inducer of cytokine production in rat and human Kupffer cells in vitro. Surgical Infections 4: 181-191.

Pettersen I, Bakkelund W, Smedsrød B, Sveinbjørnsson B. 2005. Osteoprotegerin is expressed in colon carimona cells. Anticancer Research 25: 3809-3816.

Politz O, Gratchev A, McCourt PAG, Schledzewski K, Guillot P, Johansson S, Svineng G, Franke P, Kannicht C, Kzhyshkowska J, Longati P, Velten FW, Goerdt S. 2002. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochemical Journal 362:155-164.

Sano, H, Higashi, T, Matsumoto, K, Melkko, J, Jimmouchi, Y, Ikeda, K, Ebina, Y, Makino, H, Smedsrod, B, Horiuchi, S. 1998. Insulin enhances macrophage scavenger receptor-mediated endocytic uptake of advanced glycation end products. Journal of Biological Chemistry 273: 8630–8637.

Seternes T, Martin-Armas M, Smedsrød B. 2003. High lactate production assigns a role of vertebrate scavenger endothelial cells as cellular power plants. 9th International Congress of the International Society for Developmental and Comparative Immunology, St. Andrews, Scotland.

Smedsrød B, Sørensen K, Crossly CA, Seternes T. 2003. Scavenger endothelial cells of vertebrates: Anonperipheral leucocyte system for high-capacity elimination of waste macromolecules. 9th International Congress of the International Society for Developmental and Comparative Immunology, St. Andrews, Scotland.

Svistounov D, Berg TJ, McCourt PAG, Zykova SN, Elvevold KH, Nagai R, Horiuchi S, Smedsrød BH. 2003. Lack of recognition of Ne-(carboxymethyl)lysine by the mouse liver reticulo-endothelial system: implications for pathophysiology. Biochemical and Biophysical Research 309: 786-791.

Matti Viitanen:
Aguero-Torres H, von Strauss E, Viitanen M, Winblad B, Fratiglioni L. 2001. Institutionalization in the elderly: the role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study. Journal of Clinical Epidemiology 54: 795-801.

Corder EH, Basum H, Fratiglioni L, Guo Z, Lannfelt L, Viitanen M, Corder LS, Manton KG, Winblad B. 2000. Inhereted frailty. ApoE alleles determine survival after a diagnosis of heart disease or stroke at ages 85+. Annales of the New York Academy of Sciences 908: 295-298.

Frisoni GB, Fratiglioni L, Fastbom J, Guo Z, Viitanen M, Winblad B. 2000. Mild cognitive impairment in the population and physical health: data 1,435 individuals aged 75 to 95. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 55: M322-M328.

Froelich Fabre, S. Forsell C, Viitanen M, Sjögren M, Wallin A, Blennow K, Blomberg M, Andersen C, Wahlund L-O, Lannfelt L. 2001. Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau, high apolipoprotein E e4 frequency, but no tau gene mutations. Experimental Neurology 168: 413-418.

Hjalmarsen A, Vittanen M, Jenssen T, Jorde R, Johansen O. 2000. Plasma beta-endorphin concentrations are increased in chronic obstructiv pulmonary disease. Scandinavian Journal of Clinical and Laboratory Investigation 60: 501-506.

Ingelson M, Fabre SF, Lilius L, Andersen C, Viitanen M, Almkvist O, Wahlund LO, Lannfelt L. 2001. Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon4. Neuroreport 12: 905-9.

Louhija J, Viitanen M, Aguero-Torres H, Tilvis R. 2001. Survival of Finnish centenarians in relation to apolipoprotein E polymorphism. Journal of the American Geriatrics Society 49: 1007-1008.

Mattila KM, AxelmanK, Rinne JO, Blomberg M, Lehtimäki T, Laippala P, Röyttä M, Viitanen M, Wahlund L, Winblad B, Lannfelt L. 2000. Interaction between estrogen receptor 1 and e4 allele of apolipoprotein E increases the risk of familial Alzheimer’s disease in women. Neuroscience Letters 282: 45-48.

Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L. 2000. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Archives of Neurology 57: 839-844.

Sonde L, Kalimo H, Feraneus SE, Viitanen M. 2000. Low TENS treatment on post-stroke paretic arm: a three-year follow-up. Clinical Rehabilitation 14: 14-19.

Sonde L, Kalimo H, Viitanen M. 2000. Stimulation with high-frequency TENS – effects on lower limb spacticity after stroke. Advances in Physiotherapy 14: 14-19.

Sonde L, Viitanen M. 2001. Length of hospital stay, functional independence and life satisfaction after stroke. International Journal of Rehabilitation Research 24:73-78.

Sonde L, Lökk J, Nilsson CG, Viitanen M. 2001. A double-blind placebo-controlled study of effects of amphetamine and physiotherapy after stroke. Cerebrovascular Diseases 12: 253-257.

Tuominen S, Juvonen V, Jolma T, Amberla K, Rinne J, Tuisku S, Kurki T, Marttila R, Pöyhönen M, Savontaus M-L, Kalimo H, Viitanen M. 2001. Homozygosity for R133C Notch 3 mutation in CADASIL causes minor aggravation of the clinical picture. Stroke 32: 1767-74.

Verkkoniemi A, Somer M, Rinne JO, Myllykangas L, Crook R, Hardy J, Viitanen M, Kalimo H, Haltia M. 2000. Variant Alzheimer’s disease with spastic paraparesis. Clinical characterization. Neurology 54: 1103-1109.

Zhenchao G, Fratiglioni G, Viitanen M, Lannfelt L, Basun H, Fastbom J, Winblad B. 2001. Apolipoprotein E genotypes and incidence of Alzheimer´s disease among persons 75 years and older: variation by use of antihypertensive medication? American Journal of Epidemiology 153: 225-31.

Zhu L, Fratiglioni L, Guo Z, Basun H, Corder EH, Winblad B, Viitanen M. 2000. Incidence of dementia in relation to stroke and the apolipoprotein E e4 allele in the very old. Findings from a population-based longitudinal study. Stroke 31: 53-60.

Zhu L, Fratiglioni L, Guo Z, Winblad B, Viitanen M. 2000. Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project. Neurology 54: 2103-2107.

SAMFUNNSFAGLIG FORSKNING:
Kari Brøndbo
Brøndbo K. 2000. Fra likegyldighet til samarbeid? I: Aldring i nord: Livssituasjon, hjelpebehov og mestring i den fjerde alder (ed.: Kirsten Thorsen). Senter for aldersforskning i Tromsø, Rapport nr. 2: 41-48.

Trine Medby Fossland:
Fossland TM. 2000. Fra "grissgrent" tilværelse til bokollektiv i siste fase av livsløpet. I: Aldring i nord: Livssituasjon, hjelpebehov og mestring i den fjerde alder (ed.: Kirsten Thorsen). Senter for aldersforskning i Tromsø, Rapport nr. 2: 28-34.

Fossland, TM. 2001. Livshistorier og biografier som forskningstilnærming. I: Tilnærminger til sosialgerontologien (ed.: Kirsten Thorsen). Senter for aldersforskning i Tromsø, Rapport nr. 1: 30-45.

Fossland TM. 2001. På langs og på tvers (anmeldelse av Hanne Haavinds bok "Kjønn og fortolkende metode – Metodiske muligheter i kvalitativ forskning", Oslo: Gyldendal Norsk Forlag 2000). Tidsskrift for kvinneforskning 3.

Fossland TM. 2005. Livsløp i endring. En sosiologisk studie av ulike grupper eldres fortellinger om sine liv. Thesis, University of Tromsø. 232 sider.

Hege Gjertsen:
Gjertsen H. 2000. Hvorfor tar gamle menn sitt eget liv? I: Aldring i nord: Livssituasjon, hjelpebehov og mestring i den fjerde alder (ed.: Kirsten Thorsen). Senter for aldersforskning i Tromsø, Rapport nr. 2: 49-58.

Gjertsen H. 2001. Individ-samfunn problematikken i lys av virksomhetsteorien. I: Tilnærminger til sosialgerontologien (ed.: Kirsten Thorsen). Senter for aldersforskning i Tromsø, Rapport nr. 1: 46-68.

Gjertsen H. 2005. Tap av ektefelle i eldre år: Sorg og mestring. Thesis, University of Tromsø. 347 sider.

Magnhild Nicolaisen:
Nicolaisen M. 2001. Årsaker til pensjonering blant ”nye eldre”. I: Tilnærminger til sosialgerontologien (ed.: Kirsten Thorsen). Senter for aldersforskning i Tromsø, Rapport nr. 1: 69-85.

Nicolaisen M. 2002. Arbeid, tilbaketrekning, utstøtning og pensjonering. Når mennesker med funksjonshemming trer ut av arbeidslivet. Rapport fra FoA (Funksjonshemming og Aldring), Nasjonalt kompetansesenter for aldersdemens, Oslo. 80 sider.

Kirsten Thorsen:
Dahle R, Thorsen, K. 2004. Velferdstjenester i endring. Når politikk blir praksis. Fagbokforlaget, Bergen.

Thorsen K. 2000. Aldring i nord: livssituasjon, hjelpebehov og mestring i den fjerde alder. Rapport nr. 2. Senter for aldersforskning i Tromsø. 69 sider.

Thorsen K. 2001. Tilnærminger til sosialgerontologien. Livskvalitet, livshistorier, virksomhet og pensjonering. Rapport nr. 1. Senter for aldersforskning i Tromsø. 87 sider.

HELSEFAGLIG FORSKNING:
Cathrine Arntzen:
Arntzen C. 2003. Kroppen og livet – En studie basert på livshistorier om å leve et langt liv med en poliorammet kropp. Rapport fra FoA (Funksjonshemming og Aldring), Nasjonalt kompetansesenter for aldersdemens, Oslo. 139 side

Arntzen C. 2006. Kapittel i Eldreomsorgens ABC. Loft-Funksjonshemming og aldring. Forlaget Aldring og helse. ISBN 978-82-8061-068-3

Lone Jørgensen:
Jørgensen L, Engstad T, Jacobsen BK. 2002. Higher incidence of falls in long-term stroke survivors than in population controls. Depressive symptoms predict falls after stroke. Stroke 33: 542-547.

Jørgensen L. 2001. Fragile bones in patients with stroke? Bone mineral density in acute stroke patients and changes during one year of follow up. Thesis, University of Tromsø, Norway.

Jørgensen L, Engstad T, Jacobsen BK. 2001. Bone mineral density in acute stroke patients: low bone mineral density may predict first stroke in women. Stroke 32: 47-51.

Jørgensen, L and Jacobsen, BK. 2001. Functional status of the paretic arm affects the loss of bone mineral in the proximal humerus after stroke. A one-year prospective study. Calcified Tissue International 68: 11-15.

Jørgensen L, Jacobsen BK. 2001. Changes in muscle mass, fat mass and bone mineral content of the legs after stroke. A one-year prospective study. Bone 28:655-659.

Jørgensen L. 2001. Fragile bones in patients with stroke; bone loss affected by motor function. Jubiläumsschrift Burgau 152-157.

Jørgensen L, Jacobsen BK, Wilsgaard T, Magnus JH. 2000. Walking after stroke: does it matter? Changes in bone mineral density within the first 12 months after stroke. A longitudinal study. Osteoporosis International 11:381-387.

Jørgensen L, Crabtree NJ, Reeve J, Jacobsen BK. 2000. Ambulatory level and asymmetrical weight bearing after stroke affects bone loss in the upper and lower part of the femoral neck differently: bone adaptation after decreased mechanical loading. Bone 27: 701-707.

Jørgensen L. 1997. Osteoporose-udvikling hos patienter med apoplexia cerebri: En kortlægning af ændringerne i knoglemineralindholdet i proximale femur, i underekstremiteterne generelt og i columna i løbet af de første to måneder efter sygdomsstart -et longitudinelt studie. Hovedfagsopgave, Universitetet i Bergen.

Ketil Normann:
Asplund K og Normann HK. 2002. Episoder av psykisk klarhet hos personer med svår demenssjukdom. I: Edberg AK (red.). Att möta personer med demens. Studentlitteratur, Lund: Sverige, s. 82-95.

Normann HK. 2001. Lucidity in people with severe dementia as a consequense of person-centred care. Umeå University Medical Dissertations. New series No 753. Solfjädern Offset AB, Umeå.

Normann HK, Asplund K, Nordberg A. 1999. Attitudes of Registered Nurses towards patients with severe dementia. Journal of Clinical Nursing 8: 353-359.

Normann HK. 1999. Kommunikasjon med personer med alvorlig demens. Fysioterapeuten 10: 15-18.

Normann HK. 1999. Kommunikasjon med personer med alvorlig aldersdemens. Demens 3/4: 25-28.

Normann HK, Asplund K, Norberg A. 1998. Episodes of lucidity in people with severe dementia as narrated by formal carers. Journal of Advanced Nursing 28: 1295-1300.

Normann HK. 1998. Livssituasjonen til pasienter med aldersdemens - skal den forklares og/eller forstås? I: Fagermoen MS, Nord R, Hanestad B, Björnsborg E (red.). Fra kunst til kolikk. Norsk sykepleieforskning i fokus. Oslo: Universitetsforlaget.